Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival

Stroke

Volumn 43, Issue 1, 2012, Pages 147-154

  Flint, Alexander C ^a   Kamel, Hooman ^c   Navi, Babak B ^c   Rao, Vivek A ^a   Faigeles, Bonnie S ^a   Conell, Carol ^b   Klingman, Jeff G ^a   Sidney, Stephen ^b   Hills, Nancy K ^c   Sorel, Michael ^b   Cullen, Sean P ^a   Johnston, S Claiborne ^b,c  

^a KAISER PERMANENTE   (United States)

^b DIVISION OF RESEARCH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

brain ischemia; outcomes; statins; stroke management; survival analysis

Indexed keywords

STATIN;

AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; HOSPITALIZATION; HUMAN; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; STROKE; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84855344320     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.627729     Document Type: Article

References (32)

1. Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol. 2009;8:453-463.
2. O'Regan C, Wu P, Arora P, Perri D, Mills EJ. Statin therapy in stroke prevention: a meta-analysis involving 121 000 patients. Am J Med. 2008; 121:24-33.
3. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549-559.
4. Elkind MSV, Flint AC, Sciacca RR, Sacco RL. Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality. Neurology. 2005;65:253-258. (Pubitemid 41022370)
5. Martí-Fàbregas J, Gomis M, Arboix A, Aleu A, Pagonabarraga J, Belvís R, et al. Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke. 2004;35:1117-1121. (Pubitemid 38543528)
6. Moonis M, Kane K, Schwiderski U, Sandage BW, Fisher M. HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke. 2005;36:1298-1300. (Pubitemid 40798758)
7. Milionis HJ, Giannopoulos S, Kosmidou M, Panoulas V, Manios E, Kyritsis AP, et al. Statin therapy after first stroke reduces 10-year stroke recurrence and improves survival. Neurology. 2009;72:1816-1822.
8. Blanco M, Nombela F, Castellanos M, Rodriguez-Yáñez M, García-Gil M, Leira R, et al. Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology. 2007;69:904-910. (Pubitemid 47329591)
9. Colivicchi F, Bassi A, Santini M, Caltagirone C. Discontinuation of statin therapy and clinical outcome after ischemic stroke. Stroke. 2007;38: 2652-2657. (Pubitemid 47493999)
10. Calabrò P, Yeh ETH. The pleiotropic effects of statins. Curr Opin Cardiol. 2005;20:541-546. (Pubitemid 41565340)
11. Cimino M, Gelosa P, Gianella A, Nobili E, Tremoli E, Sironi L. Statins: multiple mechanisms of action in the ischemic brain. Neuroscientist. 2007;13:208-213. (Pubitemid 46801757)
12. Adams RJ, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, et al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke. 2008; 39:1647-1652.
13. Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke. Circulation. 2007;115:e478-e534.
14. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285: 2370-2375. (Pubitemid 32424106)
15. Newman TB, Brown AN. Use of commercial record linkage software and vital statistics to identify patient deaths. J Am Med Inform Assoc. 1997; 4:233-237. (Pubitemid 127431647)
16. Johnston SC, Henneman T, McCulloch CE, van der Laan M. Modeling treatment effects on binary outcomes with grouped-treatment variables and individual covariates. Am J Epidemiol. 2002;156:753-760. (Pubitemid 35155182)
17. Gillum LA, Johnston SC. Influence of physician specialty on outcomes after acute ischemic stroke. J Hosp Med. 2008;3:184-192.
18. Newhouse JP, McClellan M. Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health. 1998;19:17-34. (Pubitemid 28279922)
19. Brunton L, Lazo J, Parker K. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th ed. New York: McGraw-Hill Professional; 2005.
20. Greisenegger S, Müllner M, Tentschert S, Lang W, Lalouschek W. Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events. J Neurol Sci. 2004;221:5-10. (Pubitemid 38721284)
21. Aslanyan S, Weir CJ, McInnes GT, Reid JL, Walters MR, Lees KR. Statin administration prior to ischaemic stroke onset and survival: exploratory evidence from matched treatment-control study. Eur J Neurol. 2005;12:493-498. (Pubitemid 40956804)
22. Goldstein LB, Amarenco P, Zivin J, Messig M, Altafullah I, Callahan A, et al. Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial. Stroke. 2009;40:3526-3531.
23. Endres M. Statins and stroke. J Cereb Blood Flow Metab. 2005;25: 1093-1110. (Pubitemid 41710736)
24. Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2004;45:89-118.
25. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
26. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet. 2007;370:1829-1839.
27. Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet. 1995;346:1647-1653.
28. Gertz K, Laufs U, Lindauer U, Nickenig G, Böhm M, Dirnagl U, et al. Withdrawal of statin treatment abrogates stroke protection in mice. Stroke. 2003;34:551-557. (Pubitemid 36206363)
29. del Zoppo GJ. The neurovascular unit in the setting of stroke. J Intern Med. 2010;267:156-171.
30. del Zoppo GL. Stroke and neurovascular protection. N Engl J Med. 354:553-555.
31. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et al. Primary prevention of ischemic stroke. Stroke. 2006;37:1583-1633.
32. Joint Commission Specifications Manual for National Hospital Quality Measures. Available at: www.jointcommission.org/specifications-manual-for- national-hospital-inpatient-quality-measures/. Accessed January 2011.